ContextVision AB - Report Publication Announcement 2026

Correction: Annual report financial calendar Q1 interim report date

ContextVision refers to the financial calendar included in the Annual Report

for 2025, published on 8th April 2026.

The date for the Q1 interim report was incorrectly stated in the Annual

Report. The correct publication date for the Q1 interim report is 8th of May

2026, in line with previously communicated information to the market.

The financial calendar available on ContextVision's website and via market

data providers reflects the correct date.

No other dates or information are affected.

For further information, please contact:

Richard Hallström, CFO

About ContextVision AB:

ContextVision is a medical technology software company specialized in image

analysis and artificial intelligence. As the global market leader within image

enhancement, we are a trusted partner to leading manufacturers of ultrasound,

X-ray and MRI equipment around the world. Our expertise is to develop powerful

software products, based on proprietary technology and artificial intelligence

for image-based applications. Our cutting-edge technology helps clinicians

accurately interpret medical images, a crucial foundation for better diagnosis

and treatment. The company, established in 1983, is based in Sweden with local

representation in the U.S., Japan, China and Korea. ContextVision is listed on

the Oslo Stock Exchange under the ticker CONTX.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR. The information was submitted for publication, through the

agency of the contact persons set out above, at 2026-04-24 08:00 CEST.

AI assistant